Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Kailera Therapeutics
Entity

Kailera Therapeutics

Tracked across 2 events · 14 articles · First seen Apr 16, 2026 · Last active May 28, 2026

Sentiment
58
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 75
Business
Kailera Therapeutics Completes IPO
Impact: Kailera Therapeutics successfully completed its initial public offering, raising $718.8 million and listing its common stock on the Nasdaq-100 Global Select Market under the ticker symbol 'KLRA'. This event marks its transition to a publicly traded company.
Apr 16, 2026 · 8 articles
4 40
Business
PatentVest Report on Obesity Drug IP
PatentVest, a division of MDB Capital Holdings, released a comprehensive report titled 'The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market' on May 8, 2026. The report analyzes…
Impact: Kailera Therapeutics is identified as an emerging player in the development of next-generation obesity therapeutics.
May 08, 2026 · 6 articles
NEWSDESK
Track Kailera Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.